PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line

Cell Biology International

Volumn 38, Issue 4, 2014, Pages 502-510

  Tang, Tao ^a   Song, Xin ^a   Liu, Yu Fen ^a   Wang, Wen Yue ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Gastric cancer; Multi drug resistance; Phenethyl isothiocyanate

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PHENETHYL ISOTHIOCYANATE; PROTEIN KINASE B; PROTEIN MAD2; REACTIVE OXYGEN METABOLITE; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CYCLE CHECKPOINT; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ERCC1 GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MDR1 GENE; MRP1 GENE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STOMACH CANCER; SURVIVIN GENE; TRANSCRIPTION INITIATION;

GASTRIC CANCER; MULTI-DRUG RESISTANCE; PHENETHYL ISOTHIOCYANATE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CISPLATIN; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENDONUCLEASES; GLUTATHIONE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; ISOTHIOCYANATES; MAD2 PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NF-KAPPA B; P-GLYCOPROTEIN; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84895874955     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10169     Document Type: Article

References (18)

1. Chen PY, Lin KC, Lin JP, Tang NY, Yang JS, Lu KW, Chung JG (2012) Phenethyl Isothiocyanate (PEITC) inhibits the growth of human oral squamous carcinoma HSC-3 cells through G(0)/G(1) phase arrest and mitochondria-mediated apoptotic cell death. Evid Based Complement AlternatMed 2012: 718320.
2. Conaway CC, Yang YM, Chung FL (2002) Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 3: 233-55.
3. Dick RA, Kensler TW (2002) Chemoprotective potential of phase 2 enzyme inducers. Expert Rev Anticancer Ther 2: 581-92.
4. Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y, Cao S, Qiao T, Chen Z, Fan D (2005) Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 4: 1936-42.
5. Lai KC, Huang ANC, Hsu SC, Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS, Wu SH, Chung JG (2010) Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J Agric Food Chem 58(5): 2935-42.
6. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
7. Pawlik A, Szczepanski MA, Klimaszewska A, Gackowska L, Zuryn A, Grzanka A (2012) Phenethyl isothiocyanate-induced cytoskeletal changes and cell death in lung cancer cells. Food Chem Toxicol 50(10): 3577-94.
8. Pullar JM, Thomson SJ, King MJ, Turnbull CI, Midwinter RG, Hampton MB (2004) The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated Apoptosis. Carcinogenesis, 25(5): 765-72.
9. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et al (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-7.
10. Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169: 110-5.
11. Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L (2006) Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecol Oncol 103(1): 261-70.
12. Scala S, Dickstein B, Regis J, et al (1995) Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrugresistant human breast cancer cells. Clin Cancer Res 1: 1581-7.
13. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1): 10-29.
14. Syed Alwi SS, Cavell BE, Donlevy A, Packham G (2012) Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent. Cell Stress Chaperones 17(5): 529-38.
15. Thomson SJ, Brown KK, Pullar JM, Hampton MB (2006) Phenethyl isothiocyanate triggers apoptosis in Jurkat cells made resistant by the overexpression of Bcl-2. Cancer Res 66: 6772-7.
16. Trachootham D, Zhang H, ZhangW, Feng L, Du M, Zhou Y, Chen Z, Pelicano H, Plunkett W, Wierda WG, Keating MJ, Huang P (2008) Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 112(5): 1912-22.
17. Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL, Yu CS, Lin ML, Yang JS, Kuo HM, Wu SH, Chung JG (2010) Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-B signal pathways. Anticancer Res 30: 2135-43.
18. Zhang Y (2004) Cancer preventive isothiocyanates: measurement of human exposure and mechanism of action, Mutation Research, 555: 173-90.